Related Experiment Video
Updated: May 30, 2026
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Economic analyses in cardiac electrophysiology: from clinical efficacy to cost utility
Maria Hee Jung Park Frausing1,2, Jens Cosedis Nielsen1,2, Caroline Louise Westergaard3
1Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Bvld 99, DK-8200 Aarhus, Denmark.
Insights
Cost-effectiveness analyses are crucial for evaluating new cardiac electrophysiology technologies. This paper introduces their concepts, framework, and limitations for clinicians, aiding rational healthcare decisions.
Area of Science:
- Cardiac electrophysiology
- Health economics
- Medical device technology
Background:
- Cardiac electrophysiology relies on expensive device- and catheter-based technologies.
- Increasing patient eligibility for interventions due to atrial fibrillation and longevity necessitates cost-conscious approaches.
- Finite healthcare resources demand evaluation of new technologies' value.
Purpose of the Study:
- To introduce cost-effectiveness analyses (CEAs) to clinicians.
- To explain the basic concepts, framework, and limitations of CEAs.
- To provide recent examples from clinical electrophysiology and device therapy.
Main Methods:
- Review of cost-effectiveness analysis principles.
- Discussion of CEA framework and potential biases.
- Inclusion of case examples from cardiac electrophysiology.
Main Results:
- Cost-effectiveness analyses provide a ratio of healthcare costs to health benefits.
- CEAs support rational decision-making in healthcare resource allocation.
- Significant uncertainty and bias can affect CEA outcomes.
Conclusions:
- Understanding cost-effectiveness analyses is vital for clinicians in cardiac electrophysiology.
- CEAs help navigate the economic challenges of new cardiac technologies.
- Awareness of CEA limitations is essential for accurate interpretation and application.
Abstract:
Cardiac electrophysiology is an evolving field that relies heavily on costly device- and catheter-based technologies. An increasing number of patients with heart rhythm disorders are becoming eligible for cardiac interventions, not least due to the rising prevalence of atrial fibrillation and increased longevity in the population. Meanwhile, the expansive costs of healthcare face finite societal resources, and a cost-conscious approach to new technologies is critical. Cost-effectiveness analyses support rational decision-making in healthcare by evaluating the ratio of healthcare costs to health benefits for competing therapies. They may, however, be subject to significant uncertainty and bias. This paper aims to introduce the basic concepts, framework, and limitations of cost-effectiveness analyses to clinicians including recent examples from clinical electrophysiology and device therapy.
Related Concept Videos
01:15Pharmacodynamic Models: Linear Concentration–Effect Model
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions